CryoLife to Present at 36th Annual Canaccord Genuity Growth Conference

CryoLife to Present at 36th Annual Canaccord Genuity Growth Conference

PR Newswire

ATLANTA, Aug. 4, 2016 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it will participate in the upcoming 36th Annual Canaccord Genuity Annual Growth Conference on Wednesday, August 10, 2016 in Boston, MA.

Cryolife logo. (PRNewsFoto/CryoLife, Inc.) (PRNewsFoto/CRYOLIFE_ INC_)

A live webcast of the Company's presentation is scheduled to begin at 12:30 p.m. ET and will feature an overview of the company and fireside chat with Pat Mackin, Chairman, President and Chief Executive Officer.

The live webcast can be accessed through CryoLife's website, www.cryolife.com, on the Investor Relations page.  An archived copy of the webcast will be available for 90 days on the same website.

About CryoLife

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac surgical procedures.  CryoLife markets and sells products in more than 80 countries worldwide.  For additional information about CryoLife, visit our website, www.cryolife.com.

Contacts:






CryoLife

The Ruth Group


D. Ashley Lee

Nick Laudico / Zack Kubow


Executive Vice President, Chief Financial Officer

646-536-7030 / 7020


and Chief Operating Officer

[email protected]


Phone: 770-419-3355

[email protected]

Logo - http://photos.prnewswire.com/prnh/20140319/MM86518LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cryolife-to-present-at-36th-annual-canaccord-genuity-growth-conference-300309600.html

SOURCE CryoLife, Inc.

Copyright CNW Group 2016